References
Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000; 91: 66–7.
McDonald J, Bayrak-Toydemir P, Pyeritz RE. Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis. Genet Med 2011; 13: 607–16.
Donaldson JW, McKeever TM, Hall IP, Hubbard RB, Fogarty AW. The UK prevalence of hereditary haemorrhagic telangiectasia and its association with sex, socioeconomic status and region of residence: a population-based study. Thorax 2014; 69: 161–7.
Lebrin F, Srun S, Raymond K, et al. Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat Med 2010; 16: 420–8.
Halachmi S, Israeli H, Ben-Amitai D, Lapidoth M. Treatment of the skin manifestations of hereditary hemorrhagic telangiectasia with pulsed dye laser. Lasers Med Sci 2014; 29: 321–4.
Papaspyrou G, Schick B, Al Kadah B. Nd:YAG laser treatment for extranasal telangiectasias: a retrospective analysis of 38 patients with hereditary hemorrhagic telangiectasia and review of the literature. ORL J Otorhinolaryngol Relat Spec 2016; 78: 245–51.
Lyons GD, Owens RE, Mouney DF. Argon laser destruction of cutaneous telangiectatic lesions. Laryngoscope 1981; 91: 1322–5.
Yu W, Ma G, Qiu Y, et al. Prospective comparison treatment of 595-nm pulsed-dye lasers for virgin port-wine stain. Br J Dermatol 2015; 172: 684–91.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Nishikawa, J., Fujii, N., Kato, T. et al. Successful treatment of hereditary haemorrhagic telangiectasia using 595-nm pulsed dye laser. Eur J Dermatol 27, 674–675 (2017). https://doi.org/10.1684/ejd.2017.3144
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2017.3144